Skip to main content
65°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
29.42
-0.24 (-0.81%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
34
35
Next >
Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
January 18, 2023
Johnson & Johnson stock has been struggling to break out of a correction. It formed a cup-shaped pattern that appeared to add a handle but broke down last week.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries
January 17, 2023
From
Pfizer Inc.
Via
Business Wire
"CDC, FDA…link between Pfizer's shot & strokes" 2 years after FDA warning; Media Failing US: Expert
January 15, 2023
January 15, 2023 -- FDA's warning of death, strokes, and serious reactions from the shot posted at https://www.fda.gov/media/143557/download pg 16 Oct 22, 2020 were never reported by media, says...
Via
24-7 Press Release
Exposures
Product Safety
Direct to Consumer Pharmaceutical Advertising Market Is Going to Boom : Pfizer, Merck, GlaxoSmithKline
January 11, 2023
Stay up-to-date with Direct To Consumer Pharmaceutical Advertising Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Atypical Digital, A Global Digital Marketing Tech Enabled Company, acquires South Korea-based Springworks
January 10, 2023
Via
AB Newswire
Four Undervalued Healthcare Stocks for 2023
January 06, 2023
These four health care stocks could be undervalued: Pfizer Inc., Regeneron Pharmaceuticals Inc., Innoviva Inc. and Exelixis Inc.
Via
MarketBeat
Exposures
COVID-19
A Comprehensive Study Exploring Nephroblastoma Treatment Market: Key Players Bayer HealthCare, Pfizer, AstraZeneca
January 06, 2023
Get an extensive Nephroblastoma Treatment Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.
Via
SBWire
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine in Infants and Children
January 06, 2023
From
Pfizer Inc.
Via
Business Wire
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
January 03, 2023
From
Pfizer Inc.
Via
Business Wire
The Year of the Tripledemic
January 03, 2023
COVID-19 may have lost its daily news headline status, but the disease rages on with 2700 weekly deaths in the U.S. and millions of Americans chronically disabled from long-COVID, 4 million of which...
Via
TheNewswire.com
Topics
Death
Exposures
COVID-19
Death
Product Safety
Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate
December 29, 2022
From
Pfizer Inc.
Via
Business Wire
Big Health Care Stocks to Watch in the New Year
December 29, 2022
Here are three health care stocks to watch as the New Year begins. Two have a moderate Buy rating while one is a Hold, for now.
Via
MarketBeat
U.S. FDA Accepts for Review the Biologics License Application for Pfizer’s Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents
December 28, 2022
From
Pfizer Inc.
Via
Business Wire
Why Did Immutep Ltd Stock Soar Recently?
December 28, 2022
Analysts and investors alike appear enamored with Immutep Ltd, whose earnings are growing; more of which could come from their latest product candidate.
Via
MarketBeat
Topics
Initial Public Offering
Exposures
Product Safety
Securities Market
Vaccines & Vaccination Market May Set Epic Growth Story : Pfizer, Merck, Johnson & Johnson
December 22, 2022
Stay up-to-date with Vaccines & Vaccination Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
DeepThink Health Appoints Krish Ghosh as Executive Vice President and General Manager, Life Sciences
December 28, 2022
Ghosh Brings Three Decades of Life Sciences Experience to DeepThink HealthSAN RAMON, Calif. - Dec. 28, 2022 - PRLog -- DeepThink Health, Inc., an AI-powered leader in the transformation of health data...
Via
PRLog
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis
December 21, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts
December 20, 2022
From
Pfizer Inc.
Via
Business Wire
Eli Lilly Expects Enduring Growth, Despite Immediate Challenges
December 19, 2022
Eli Lilly & Co may be struggling with supply-side issues but new partnerships and a healthy dividend are helping to keep up their momentum
Via
MarketBeat
Pfizer Opts In to LianBio Rights to Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir in Mainland China, Hong Kong, Macau, and Singapore
December 19, 2022
From
LianBio; Pfizer Inc.
Via
GlobeNewswire
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
December 14, 2022
Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX) are ramping up efforts to help reduce or eliminate the growing...
Via
TheNewswire.com
Topics
Death
Exposures
Death
NYSE:PFE Investor Notice: Investigation over Breaches of Fiduciary Duties at Pfizer Inc.
December 13, 2022
San Diego, CA -- (SBWIRE) -- 12/13/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Pfizer Inc.
Via
SBWire
Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trial
December 10, 2022
From
Pfizer Inc.
Via
Business Wire
MarketBeat: Week in Review 12/05 – 12/09
December 10, 2022
The markets continue to have a lot to digest before there can be a Santa Claus raly. Here are some of the top stories our analysts were covering this week.
Via
MarketBeat
Topics
Economy
Electric Vehicles
Supply Chain
Exposures
Electric Vehicles
Interest Rates
Supply Chain
Pfizer Declares First-Quarter 2023 Dividend
December 09, 2022
From
Pfizer Inc.
Via
Business Wire
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
December 09, 2022
Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months.
Via
MarketBeat
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
December 08, 2022
From
Pfizer Inc.
Via
Business Wire
AAPS Executive Director in Journal of American Physicians and Surgeons Discusses Whether Blood Clots After COVID Vaccines Are an Ignored Crisis
December 07, 2022
Despite official reassurances that adverse effects of COVID vaccines are rare or mild, some patients still have concerns, and social media is filled with reports. In the winter issue of the Journal of...
Via
Newswire.com
Exposures
COVID-19
U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer’s Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV Disease in Older Adults
December 07, 2022
From
Pfizer Inc.
Via
Business Wire
Nanomedicine Market Size & Share Report 2022 : Reach at US$ 238.4 Bn and Grow at Healthy CAGR 10.1% During Forecast Period 2022-2028
December 06, 2022
"Emerging innovative technologies for drug delivery, the benefits of nanomedicine in various healthcare applications, and the increase in the demand for safe and inexpensive treatments drive the growth...
Via
SBWire
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
34
35
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.